Sunekos Cell 15

In the evolutionary phases (I-IV) of cellulite, clinically called “Edematous Fibrosclerotic Panniculopathy” (EFP) the intradermal therapy was mainly addressed to the treatment of edema and microcirculation.

Today, numerous pathophysiological considerations demonstrate the need to intervene also and especially on the Extra Cellular Matrix (ECM).

The synergy of the mix of HA, AA and an Alkaline Solution[1]:

Sunekos Cell acts:

• Promotes the optimization of the ECM protein turnover: neo-collagenesis and not collagenase. (HA + AA)
• Improves the micro-circulation
• Re-equilibrium of the ECM inflammation reducing fibrosis
• Helps to regulate the physiological pH